BIOGRAPHY
Dr. David J Leggat is an academia and biotechnology experienced researcher in the field of Influenza vaccination and detection. Dr. Leggat received his Ph.D. from the University of Toledo Health Science Campus within the department of Medicine and the Infection, Immunity & Transplantation track studying pneumococcal vaccination in HIV and elderly patients. Expanding on his experience in flow cytometry, he joined the Vaccine Research Center at the National Institutes of Health as a post-doc where he drove HIV-specific B cell analysis for pre-clinical and clinical samples. He transitioned as a contract scientist within the Vaccine Immunology Program, leading the HIV-specific B cell analysis post-vaccination for Bill & Melinda Gates Foundation funded studies with IAVI as part of the CAVD. These efforts resulted in the first-in-human demonstration of the germline targeting HIV vaccine strategy as well as the identification of vaccine-specific antibody secreting cells in blood and bone marrow.
Dr. Leggat joined MHRP as a government civilian in 2022 serving as a Section Chief for the Cellular Immune Monitoring and Flow Cytometry cores. He primarily focuses on the study of antigen-specific cellular responses in pre-clinical and clinical trials. He is currently focused on enhancing/utilizing MHRPs spectral flow cytometry analyzers and sorter.